Logo image of PCT

PURECYCLE TECHNOLOGIES INC (PCT) Stock Fundamental Analysis

NASDAQ:PCT - Nasdaq - US74623V1035 - Common Stock - Currency: USD

6.3  -0.09 (-1.41%)

After market: 6.22 -0.08 (-1.27%)

Fundamental Rating

1

Overall PCT gets a fundamental rating of 1 out of 10. We evaluated PCT against 85 industry peers in the Chemicals industry. PCT may be in some trouble as it scores bad on both profitability and health. PCT does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

PCT had negative earnings in the past year.
PCT had a negative operating cash flow in the past year.
PCT had negative earnings in each of the past 5 years.
PCT had a negative operating cash flow in each of the past 5 years.
PCT Yearly Net Income VS EBIT VS OCF VS FCFPCT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -100M -200M -300M

1.2 Ratios

With a Return On Assets value of -36.22%, PCT is not doing good in the industry: 88.24% of the companies in the same industry are doing better.
PCT has a Return On Equity of -160.23%. This is amonst the worse of the industry: PCT underperforms 89.41% of its industry peers.
Industry RankSector Rank
ROA -36.22%
ROE -160.23%
ROIC N/A
ROA(3y)-18.61%
ROA(5y)-13.78%
ROE(3y)-67.01%
ROE(5y)-44.56%
ROIC(3y)N/A
ROIC(5y)N/A
PCT Yearly ROA, ROE, ROICPCT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -50 -100 -150

1.3 Margins

PCT does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PCT Yearly Profit, Operating, Gross MarginsPCT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024

More info and screens

0

2. Health

2.1 Basic Checks

The number of shares outstanding for PCT has been increased compared to 1 year ago.
Compared to 5 years ago, PCT has more shares outstanding
The debt/assets ratio for PCT has been reduced compared to a year ago.
PCT Yearly Shares OutstandingPCT Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
PCT Yearly Total Debt VS Total AssetsPCT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

Based on the Altman-Z score of -0.65, we must say that PCT is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -0.65, PCT is doing worse than 82.35% of the companies in the same industry.
PCT has a Debt/Equity ratio of 1.79. This is a high value indicating a heavy dependency on external financing.
PCT's Debt to Equity ratio of 1.79 is on the low side compared to the rest of the industry. PCT is outperformed by 80.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.79
Debt/FCF N/A
Altman-Z -0.65
ROIC/WACCN/A
WACCN/A
PCT Yearly LT Debt VS Equity VS FCFPCT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

2.3 Liquidity

PCT has a Current Ratio of 0.59. This is a bad value and indicates that PCT is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.59, PCT is doing worse than 88.24% of the companies in the same industry.
PCT has a Quick Ratio of 0.59. This is a bad value and indicates that PCT is not financially healthy enough and could expect problems in meeting its short term obligations.
PCT has a Quick ratio of 0.50. This is amonst the worse of the industry: PCT underperforms 84.71% of its industry peers.
Industry RankSector Rank
Current Ratio 0.59
Quick Ratio 0.5
PCT Yearly Current Assets VS Current LiabilitesPCT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for PCT have decreased strongly by -156.78% in the last year.
EPS 1Y (TTM)-156.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-165.31%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, PCT will show a quite strong growth in Earnings Per Share. The EPS will grow by 18.27% on average per year.
PCT is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 237.39% yearly.
EPS Next Y50.82%
EPS Next 2Y27.68%
EPS Next 3Y21.22%
EPS Next 5Y18.27%
Revenue Next Year1475.23%
Revenue Next 2Y551.86%
Revenue Next 3Y393.65%
Revenue Next 5Y237.39%

3.3 Evolution

PCT Yearly Revenue VS EstimatesPCT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 500M 1B 1.5B 2B
PCT Yearly EPS VS EstimatesPCT Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 1 -1

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for PCT. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for PCT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PCT Price Earnings VS Forward Price EarningsPCT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PCT Per share dataPCT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 -1 -1.5

4.3 Compensation for Growth

A more expensive valuation may be justified as PCT's earnings are expected to grow with 21.22% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y27.68%
EPS Next 3Y21.22%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for PCT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PURECYCLE TECHNOLOGIES INC

NASDAQ:PCT (4/23/2025, 6:32:37 PM)

After market: 6.22 -0.08 (-1.27%)

6.3

-0.09 (-1.41%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)02-27 2025-02-27/bmo
Earnings (Next)05-13 2025-05-13/amc
Inst Owners69.95%
Inst Owner Change0.64%
Ins Owners3.41%
Ins Owner Change0.88%
Market Cap1.13B
Analysts75
Price Target13.46 (113.65%)
Short Float %23.89%
Short Ratio17.47
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-117.21%
Min EPS beat(2)-157.29%
Max EPS beat(2)-77.13%
EPS beat(4)0
Avg EPS beat(4)-116.37%
Min EPS beat(4)-160.9%
Max EPS beat(4)-70.15%
EPS beat(8)2
Avg EPS beat(8)-63.77%
EPS beat(12)4
Avg EPS beat(12)-45.21%
EPS beat(16)5
Avg EPS beat(16)-74.16%
Revenue beat(2)0
Avg Revenue beat(2)-100%
Min Revenue beat(2)-100%
Max Revenue beat(2)-100%
Revenue beat(4)0
Avg Revenue beat(4)-100%
Min Revenue beat(4)-100%
Max Revenue beat(4)-100%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.22%
PT rev (3m)-2.82%
EPS NQ rev (1m)3.6%
EPS NQ rev (3m)-18.97%
EPS NY rev (1m)-10.85%
EPS NY rev (3m)-10.85%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-71.61%
Revenue NY rev (1m)-10.46%
Revenue NY rev (3m)-43.73%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 6.26
P/tB 6.26
EV/EBITDA N/A
EPS(TTM)-1.61
EYN/A
EPS(NY)-0.79
Fwd EYN/A
FCF(TTM)-1.12
FCFYN/A
OCF(TTM)-0.81
OCFYN/A
SpS0
BVpS1.01
TBVpS1.01
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -36.22%
ROE -160.23%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-18.61%
ROA(5y)-13.78%
ROE(3y)-67.01%
ROE(5y)-44.56%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 1.79
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 177.47%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.59
Quick Ratio 0.5
Altman-Z -0.65
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)3032.89%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-156.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-165.31%
EPS Next Y50.82%
EPS Next 2Y27.68%
EPS Next 3Y21.22%
EPS Next 5Y18.27%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year1475.23%
Revenue Next 2Y551.86%
Revenue Next 3Y393.65%
Revenue Next 5Y237.39%
EBIT growth 1Y-27.64%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year82.83%
EBIT Next 3Y47.78%
EBIT Next 5Y55.23%
FCF growth 1Y19.45%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-52.6%
OCF growth 3YN/A
OCF growth 5YN/A